Health
The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis – DocWire News
Adv Exp Med Biol. 2021;1321:277-286. doi: 10.1007/978-3-030-59261-5_25.ABSTRACTThere is data from individual clinical trials suggesting that procalcitonin
Adv Exp Med Biol. 2021;1321:277-286. doi: 10.1007/978-3-030-59261-5_25.
ABSTRACT
There is data from individual clinical trials suggesting that procalcitonin (PCT) may be a prognostic factor in the severity of COVID-19 disease. Therefore, this systematic review and meta-analysis was performed to investigate PCT levels in severe COVID-19 patients. We searched Embase, ProQuest, MEDLINE/PubMed, Scopus, and ISI/Web of Science for studies that reported the level of PCT of patient with severe COVID-19….
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General16 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase